0001209191-22-025525.txt : 20220425 0001209191-22-025525.hdr.sgml : 20220425 20220425164029 ACCESSION NUMBER: 0001209191-22-025525 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220422 FILED AS OF DATE: 20220425 DATE AS OF CHANGE: 20220425 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harford Simon N.R. CENTRAL INDEX KEY: 0001443705 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33451 FILM NUMBER: 22850204 MAIL ADDRESS: STREET 1: AVON PRODUCTS, INC. STREET 2: 1345 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALBIREO PHARMA, INC. CENTRAL INDEX KEY: 0001322505 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 BUSINESS PHONE: 857-415-4774 MAIL ADDRESS: STREET 1: 10 POST OFFICE SQUARE STREET 2: SUITE 502 SOUTH CITY: BOSTON STATE: MA ZIP: 02109 FORMER COMPANY: FORMER CONFORMED NAME: Biodel Inc DATE OF NAME CHANGE: 20050331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-22 0 0001322505 ALBIREO PHARMA, INC. ALBO 0001443705 Harford Simon N.R. C/O ALBIREO PHARMA, INC. 53 STATE STREET, 19TH FLOOR BOSTON MA 02109 0 1 0 0 CFO and Treasurer Common Stock 2022-04-22 4 S 0 103 32.9247 D 33680 D Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Represents 7,673 shares of common stock and 26,007 restricted stock units. /s/ Jason Duncan, Attorney-in-fact 2022-04-25